Azenta, Inc. (LON:0HQ1)
London · Delayed Price · Currency is GBP · Price in USD 38.83
+0.85 (2.24%)
Jan 14, 2026, 4:15 PM GMT
Azenta Revenue
In the fiscal year ending September 30, 2025, Azenta had annual revenue of $593.82M USD with 3.55% growth. Azenta had revenue of $158.95M in the quarter ending September 30, 2025, with 5.21% growth.
Revenue
$593.82M
Revenue Growth
+3.55%
P/S Ratio
3.06
Revenue / Employee
$197.94K
Employees
3,000
Market Cap
1.35B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 593.82M | 20.37M | 3.55% |
| Sep 30, 2024 | 573.45M | 21.96M | 3.98% |
| Sep 30, 2023 | 551.49M | -4.01M | -0.72% |
| Sep 30, 2022 | 555.50M | 41.80M | 8.14% |
| Sep 30, 2021 | 513.70M | 125.17M | 32.21% |
| Sep 30, 2020 | 388.54M | 54.36M | 16.27% |
| Sep 30, 2019 | 334.18M | -297.38M | -47.09% |
| Sep 30, 2018 | 631.56M | 104.06M | 19.73% |
| Sep 30, 2017 | 527.50M | 93.49M | 21.54% |
| Sep 30, 2016 | 434.01M | -118.70M | -21.48% |
| Sep 30, 2015 | 552.71M | 69.86M | 14.47% |
| Sep 30, 2014 | 482.85M | 60.41M | 14.30% |
| Sep 30, 2013 | 422.44M | -66.54M | -13.61% |
| Sep 30, 2012 | 488.98M | -199.12M | -28.94% |
| Sep 30, 2011 | 688.11M | 95.13M | 16.04% |
| Sep 30, 2010 | 592.97M | 374.27M | 171.13% |
| Sep 30, 2009 | 218.71M | -307.66M | -58.45% |
| Sep 30, 2008 | 526.37M | -216.89M | -29.18% |
| Sep 30, 2007 | 743.26M | 135.76M | 22.35% |
| Sep 30, 2006 | 607.49M | 237.72M | 64.29% |
| Sep 30, 2005 | 369.78M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.24B |
| GSK plc | 32.17B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| Hikma Pharmaceuticals | 2.35B |
| Convatec Group | 1.72B |
| Spire Healthcare Group | 1.55B |
| Genus | 672.80M |
Azenta News
- 15 days ago - Vale and Azenta have been highlighted as Zacks Bull and Bear of the Day - Nasdaq
- 15 days ago - Bear of the Day: Azenta (AZTA) - Nasdaq
- 16 days ago - New Strong Sell Stocks for December 30th - Nasdaq
- 16 days ago - Azenta's Subsidiary To Sell B Medical Systems Business To THELEMA For $63 Mln - Nasdaq
- 17 days ago - Azenta (AZTA) to Divest B Medical Systems for $63 Million - GuruFocus
- 17 days ago - Azenta Enters Definitive Agreement for the Sale of its B Medical Systems Business to THELEMA S.À R.L. - PRNewsWire
- 27 days ago - Azenta (AZTA): Needham Analyst Raises Price Target to $44 | AZTA Stock News - GuruFocus
- 4 weeks ago - New Strong Sell Stocks for Dec. 15 - Nasdaq